SecBot SecBot
Institutional Cluster

VOR

Vor Biopharma Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed5mo ago
Institutional cluster: 5 buyers, 0 sellers (bullish)
Actionable Insight • Neutral

The buying is entirely mega-passive, reflecting index rebalancing rather than active conviction. Monitor for active fund interest (e.g., healthcare-specialist hedge funds or biotech-focused funds) as a stronger signal.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$14.09
T+0 close · Jun 11, 2026 · via day close
Latest settled
+77.79%
T+60 · $25.05
Vs SPY
+73.39%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 11 $14.09entry
  2. T+1 · 5mo ago +1.92%α +1.38% · $14.36
  3. T+5 · 5mo ago +6.60%α +6.17% · $15.02
  4. T+20 · 4mo ago +40.17%α +38.28% · $19.75
  5. T+60 · 2mo ago +77.79%α +73.39% · $25.05

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Five mega-passive institutional investors (Vanguard, BlackRock, State Street, Fidelity, Morgan Stanley) collectively more than doubled their VOR positions in Q4 2025, adding $31.8M in new holdings to reach $50.8M total. This is an index-driven rebalancing move, likely reflecting VOR's continued inclusion in growth/small-cap passive mandates, not an active conviction thesis.

Key Financial Metrics

Direction
accumulating
Buy Value
$50.8M
Net Flow
$31.8M

Institutional Positions

Net institutional flow: $31.8M

▲ Buyers (5)

InstitutionActionChangePosition ValueValue Δ
VanguardDOUBLED+632.2%$10.1M$5.0M
BlackRockDOUBLED+1248.5%$6.1M$4.4M
State StreetDOUBLED+905.7%$1.2M$750.0K
FidelityDOUBLED+968.1%$33.0M$21.5M
Morgan StanleyDOUBLED+538.8%$372.0K$155.0K

Key Facts

  • 5 institutions accumulated $31.8M net in VOR during Q4 2025, bringing aggregate holdings to $50.8M
  • Every buyer was a mega-passive fund: Vanguard, BlackRock, State Street, Fidelity, Morgan Stanley
  • All five funds DOUBLED or more their positions (range: +539% to +1249% share increases)
  • Zero institutional sellers detected in this cluster

Financial Impact

5 institutions accumulated $31.8M in new VOR holdings, increasing total disclosed institutional position value from $19.0M to $50.8M

institutional ownershipfloat concentration

Risk Factors

  • No active or catalyst-driven buyers, all accumulation is passive/index rebalancing, which carries weaker predictive signal
  • 13F data is stale (45-day lag); positions may have already been unwound or adjusted

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
85% bullish (13 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-VOR-2025-Q4

US Market Status

Market Closed · Opens in 6h 34m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 11, 2026